Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(3-Bromopropyl)-1,3-dioxolane is an organic compound characterized by its unique structure, which features a bromoalkyl group attached to a dioxolane ring. This structure endows it with specific chemical properties that make it a versatile building block in the synthesis of various compounds.

62563-07-9

Post Buying Request

62563-07-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

62563-07-9 Usage

Uses

2-(3-Bromopropyl)-1,3-dioxolane is used as a reactant in the synthesis of compounds that act as therapeutic agents. Its unique structure allows it to be a valuable component in the development of new pharmaceuticals, potentially contributing to the treatment of various medical conditions.
Used in Pharmaceutical Industry:
2-(3-Bromopropyl)-1,3-dioxolane is used as a key intermediate for the synthesis of therapeutic agents. Its incorporation into the molecular structure of these agents can enhance their pharmacological properties, such as potency, selectivity, and bioavailability, ultimately leading to improved treatment outcomes for patients.

Check Digit Verification of cas no

The CAS Registry Mumber 62563-07-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,5,6 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 62563-07:
(7*6)+(6*2)+(5*5)+(4*6)+(3*3)+(2*0)+(1*7)=119
119 % 10 = 9
So 62563-07-9 is a valid CAS Registry Number.

62563-07-9Synthetic route

4-bromoethylbutanoate
2969-81-5

4-bromoethylbutanoate

ethylene glycol
107-21-1

ethylene glycol

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: Ethyl 4-bromobutyrate With diisobutylaluminium hydride In dichloromethane at -78℃;
Stage #2: ethylene glycol With toluene-4-sulfonic acid In toluene at 90℃;
95%
Stage #1: Ethyl 4-bromobutyrate With diisobutylaluminium hydride In hexane; dichloromethane at -70 - -65℃; for 1h;
Stage #2: ethylene glycol With toluene-4-sulfonic acid In benzene for 3h; Heating;
88%
With diisobutylaluminium hydride; toluene-4-sulfonic acid In dichloromethane; benzene85%
4-bromoethylbutanoate
2969-81-5

4-bromoethylbutanoate

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: Ethyl 4-bromobutyrate With diisobutylaluminium hydride In dichloromethane at -78℃;
Stage #2: With toluene-4-sulfonic acid; ethylene glycol In benzine; dichloromethane at 90℃;
95%
4-bromobutyraldehyde
38694-47-2

4-bromobutyraldehyde

ethylene glycol
107-21-1

ethylene glycol

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 2.75h; Heating;90.5%
With toluene-4-sulfonic acid In toluene Heating;90%
With toluene-4-sulfonic acid In toluene for 1.5h; Reflux;73%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(2R,4R)-N-(2,4,6-trimethoxybenzyl)-2-methyl-4-phenyl-1,3-oxazolidine
205526-50-7

(2R,4R)-N-(2,4,6-trimethoxybenzyl)-2-methyl-4-phenyl-1,3-oxazolidine

(R)-2-[((R)-4-[1,3]Dioxolan-2-yl-1-methyl-butyl)-(2,4,6-trimethoxy-benzyl)-amino]-2-phenyl-ethanol
205526-51-8

(R)-2-[((R)-4-[1,3]Dioxolan-2-yl-1-methyl-butyl)-(2,4,6-trimethoxy-benzyl)-amino]-2-phenyl-ethanol

Conditions
ConditionsYield
With magnesium In tetrahydrofuran at 0℃; for 72h;96.4%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(2R,4R)-N-(2,4,6-trimethoxybenzyl)-2,4-diphenyl-1,3-oxazolidine
205526-45-0

(2R,4R)-N-(2,4,6-trimethoxybenzyl)-2,4-diphenyl-1,3-oxazolidine

(1S,1'R)-1-[N-(2,4,6-trimethoxybenzyl)-N-2'-hydroxy-1'-phenylethylamino]-5,5-ethylenedioxy-1-phenylpentane
205526-46-1

(1S,1'R)-1-[N-(2,4,6-trimethoxybenzyl)-N-2'-hydroxy-1'-phenylethylamino]-5,5-ethylenedioxy-1-phenylpentane

Conditions
ConditionsYield
With magnesium In tetrahydrofuran at 0℃; for 72h;96.4%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

phosphoric acid diethyl ester (R)-2-iodo-4,4-dimethylcyclohex-2-enyl ester
725739-83-3

phosphoric acid diethyl ester (R)-2-iodo-4,4-dimethylcyclohex-2-enyl ester

(R)-2-(3-(2-iodo-6,6-dimethylcyclohex-2-en-1-yl)propyl)-1,3-dioxolane
1321556-48-2

(R)-2-(3-(2-iodo-6,6-dimethylcyclohex-2-en-1-yl)propyl)-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With magnesium In tetrahydrofuran at 70℃; Inert atmosphere;
Stage #2: With copper(l) cyanide In tetrahydrofuran at -40 - 0℃; Inert atmosphere;
Stage #3: phosphoric acid diethyl ester (R)-2-iodo-4,4-dimethylcyclohex-2-enyl ester In tetrahydrofuran at -40℃; Inert atmosphere;
96%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(2R,4R)-N-(2,4,6-trimethoxybenzyl)-2-(2,2-ethylenedioxy-2-phenylethyl)-4-phenyl-1,3-oxazolidine
205440-44-4

(2R,4R)-N-(2,4,6-trimethoxybenzyl)-2-(2,2-ethylenedioxy-2-phenylethyl)-4-phenyl-1,3-oxazolidine

(R)-2-[(S)-4-[1,3]Dioxolan-2-yl-1-(2-phenyl-[1,3]dioxolan-2-ylmethyl)-butylamino]-2-phenyl-ethanol
205440-45-5

(R)-2-[(S)-4-[1,3]Dioxolan-2-yl-1-(2-phenyl-[1,3]dioxolan-2-ylmethyl)-butylamino]-2-phenyl-ethanol

Conditions
ConditionsYield
With magnesium In tetrahydrofuran at 0℃; for 48h;95.8%
cyclohexenone
930-68-7

cyclohexenone

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

3-<3-(1,3-dioxolan-2-yl)propyl>cyclohexanone
75506-74-0

3-<3-(1,3-dioxolan-2-yl)propyl>cyclohexanone

Conditions
ConditionsYield
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With magnesium In tetrahydrofuran at 22 - 24℃; for 1h;
Stage #2: cyclohexenone With copper(l) iodide In tetrahydrofuran at -78 - 0℃;
92%
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With magnesium In tetrahydrofuran at 20℃; for 1.5h;
Stage #2: With copper(l) iodide In tetrahydrofuran at -30℃; for 0.5h;
Stage #3: cyclohexenone In tetrahydrofuran at -78 - 20℃;
78%
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With magnesium In tetrahydrofuran at 20℃; for 1.5h;
Stage #2: With copper(l) iodide In tetrahydrofuran at -30℃; for 0.5h;
Stage #3: cyclohexenone In tetrahydrofuran at -78 - 20℃;
78%
5-ethoxy-pyrrolidin-2-one
39662-63-0

5-ethoxy-pyrrolidin-2-one

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

C12H21NO4
1189789-95-4

C12H21NO4

Conditions
ConditionsYield
Stage #1: 5-ethoxy-pyrrolidin-2-one With n-butyllithium In tetrahydrofuran; hexane at -78℃;
Stage #2: 2-(3-bromopropyl)-1,3-dioxolane In tetrahydrofuran; hexane; dimethyl sulfoxide at -78 - 20℃;
92%
(S)-4-(3-iodophenyl)oxazolidin-2-one

(S)-4-(3-iodophenyl)oxazolidin-2-one

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(S)-3-(3-(1,3-dioxolan-2-yl)propyl)-4-(3-iodophenyl)oxazolidin-2-one

(S)-3-(3-(1,3-dioxolan-2-yl)propyl)-4-(3-iodophenyl)oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: (S)-4-(3-iodophenyl)oxazolidin-2-one With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 2-(3-bromopropyl)-1,3-dioxolane In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 2h; Inert atmosphere;
92%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(1RS,6RS,8SR)-tricyclo<6.3.1.01,6>dodec-3-ene-2,9-dione 9,9-ethylene acetal

(1RS,6RS,8SR)-tricyclo<6.3.1.01,6>dodec-3-ene-2,9-dione 9,9-ethylene acetal

(1RS,6RS,8SR)-2-(4,4-ethylenedioxybutyl)-2-hydroxytricyclo<6.3.1.01,6>dodec-3-ene-9-one 9,9-ethylene acetal

(1RS,6RS,8SR)-2-(4,4-ethylenedioxybutyl)-2-hydroxytricyclo<6.3.1.01,6>dodec-3-ene-9-one 9,9-ethylene acetal

Conditions
ConditionsYield
With lithium In diethyl ether for 1h; Ambient temperature; Irradiation;90%
(3R,6aR,10aS,10bR)-6-(tert-Butotxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline

(3R,6aR,10aS,10bR)-6-(tert-Butotxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(3R,6R,6aR,10aS,10bR)-6-(tert-butotxycarbonyl)-6-[3-(1,3-dioxolan-2-yl)propyl]-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline

(3R,6R,6aR,10aS,10bR)-6-(tert-butotxycarbonyl)-6-[3-(1,3-dioxolan-2-yl)propyl]-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline

Conditions
ConditionsYield
Stage #1: (3R,6aR,10aS,10bR)-6-(tert-Butotxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 1h; Inert atmosphere;
Stage #2: 2-(3-bromopropyl)-1,3-dioxolane With tetra-(n-butyl)ammonium iodide In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 18h; Inert atmosphere;
90%
Allyl acetate
591-87-7

Allyl acetate

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-(hex-5-en-1-yl)-1,3-dioxolane
1005002-50-5

2-(hex-5-en-1-yl)-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With iodine; magnesium In tetrahydrofuran at 22 - 60℃; for 2h; Inert atmosphere;
Stage #2: Allyl acetate With dilithium tetrachlorocuprate In tetrahydrofuran at -20 - 22℃; for 3.5h; Inert atmosphere;
88%
N-(diphenylmethylene)glycine tert-butyl ester
81477-94-3

N-(diphenylmethylene)glycine tert-butyl ester

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(R)-tert-butyl 5-(1,3-dioxolan-2-yl)-2-(diphenylmethyleneamino)pentanoate
1416352-41-4

(R)-tert-butyl 5-(1,3-dioxolan-2-yl)-2-(diphenylmethyleneamino)pentanoate

Conditions
ConditionsYield
With cesiumhydroxide monohydrate; (R)-4,4-dibutyl-2,6-bis(3,4,5-trifluorophenyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepinium bromide In toluene at -40℃; for 16h; enantioselective reaction;87%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

isobutyric Acid
79-31-2

isobutyric Acid

5-[1,3]Dioxolan-2-yl-2,2-dimethyl-pentanoic acid

5-[1,3]Dioxolan-2-yl-2,2-dimethyl-pentanoic acid

Conditions
ConditionsYield
With N,N,N,N,N,N-hexamethylphosphoric triamide; lithium diisopropyl amide In tetrahydrofuran86%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-(4'-aminophenyl)ethyl alcohol
104-10-9

2-(4'-aminophenyl)ethyl alcohol

A

2-(4-((3-(1,3-dioxolan-2-yl)propyl)amino)phenyl)ethanol

2-(4-((3-(1,3-dioxolan-2-yl)propyl)amino)phenyl)ethanol

B

2-(4-(bis(3-(1,3-dioxolan-2-yl)propyl)amino)phenyl)ethanol

2-(4-(bis(3-(1,3-dioxolan-2-yl)propyl)amino)phenyl)ethanol

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; sodium iodide In acetonitrile at 20℃; for 20h; Inert atmosphere; Reflux;A 83%
B 13%
5-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-N-methoxy-N-methylhexanamide
1078697-21-8

5-(tert-butyldimethylsilyloxy)-6-(tert-butyldiphenylsilyloxy)-N-methoxy-N-methylhexanamide

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

8'-(tert-butyldimethylsilyloxy)-9'-(tert-butyldiphenylsilyloxy)-1'-(1,3-dioxolan-2-yl)nonan-4'-one
1078697-20-7

8'-(tert-butyldimethylsilyloxy)-9'-(tert-butyldiphenylsilyloxy)-1'-(1,3-dioxolan-2-yl)nonan-4'-one

Conditions
ConditionsYield
With iodine; magnesium; ethylene dibromide In tetrahydrofuran at 33℃; for 3h; Barbier reaction; Inert atmosphere;80%
(3R,6aR,10aS,10bR)-6-(methoxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[2,3-a]isoquinoline
864967-37-3

(3R,6aR,10aS,10bR)-6-(methoxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[2,3-a]isoquinoline

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

(3R,6R,6aR,10aS,10bR)-6-[3-(1,3-dioxolan-2-yl)propyl]-6-(methoxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline
1428872-47-2

(3R,6R,6aR,10aS,10bR)-6-[3-(1,3-dioxolan-2-yl)propyl]-6-(methoxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[3,2-a]isoquinoline

Conditions
ConditionsYield
Stage #1: (3R,6aR,10aS,10bR)-6-(methoxycarbonyl)-5-oxo-3-phenyl-2,3,6,6a,7,10,10a,10b-octahydro-5H-oxazolo[2,3-a]isoquinoline With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 1h; Inert atmosphere;
Stage #2: 2-(3-bromopropyl)-1,3-dioxolane With tetra-(n-butyl)ammonium iodide In N,N-dimethyl-formamide; mineral oil at 0 - 20℃;
80%
1-(1,1,1-trifluoroprop-2-en-2-yl)-4-methoxybenzene
69843-08-9

1-(1,1,1-trifluoroprop-2-en-2-yl)-4-methoxybenzene

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-(6,6-difluoro-5-(4-methoxyphenyl)hex-5-en-1-yl)-1,3-dioxolane

2-(6,6-difluoro-5-(4-methoxyphenyl)hex-5-en-1-yl)-1,3-dioxolane

Conditions
ConditionsYield
With 3,4,7,8-Tetramethyl-o-phenanthrolin; (η(5)-indenyl)trichlorotitanium; nickel dibromide; zinc In N,N-dimethyl acetamide at 60℃; for 24h; Schlenk technique; Inert atmosphere;79%
(E,E)-sorbyl acetate
57006-69-6

(E,E)-sorbyl acetate

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-(5E,7E)-(nona-5,7-diene-1-yl)-1,3-dioxolane
550334-68-4

2-(5E,7E)-(nona-5,7-diene-1-yl)-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With magnesium; ethylene dibromide In tetrahydrofuran at -40 - 30℃; for 1.5h;
Stage #2: (E,E)-sorbyl acetate With copper(I) bromide dimethylsulfide complex In tetrahydrofuran at -40 - 20℃; for 15h;
78%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

ethyl acetoacetate
141-97-9

ethyl acetoacetate

2-Acetyl-5-[1,3]dioxolan-2-yl-pentanoic acid ethyl ester

2-Acetyl-5-[1,3]dioxolan-2-yl-pentanoic acid ethyl ester

Conditions
ConditionsYield
With sodium hydroxide; sodium ethanolate Heating;76%
ethyl 2-cyano-2-(cyclohepta-2,4,6-trien-1-yl)acetate
1875-60-1

ethyl 2-cyano-2-(cyclohepta-2,4,6-trien-1-yl)acetate

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-Cyano-2-cyclohepta-2,4,6-trienyl-5-[1,3]dioxolan-2-yl-pentanoic acid ethyl ester

2-Cyano-2-cyclohepta-2,4,6-trienyl-5-[1,3]dioxolan-2-yl-pentanoic acid ethyl ester

Conditions
ConditionsYield
With sodium ethanolate In ethanol Heating;75%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

tetrahydrothiopyran-4-one-3-carboxylic acid allyl ester
126573-38-4

tetrahydrothiopyran-4-one-3-carboxylic acid allyl ester

3-(3-[1,3]Dioxolan-2-yl-propyl)-4-oxo-tetrahydro-thiopyran-3-carboxylic acid allyl ester
180573-65-3

3-(3-[1,3]Dioxolan-2-yl-propyl)-4-oxo-tetrahydro-thiopyran-3-carboxylic acid allyl ester

Conditions
ConditionsYield
With sodium hydride; sodium iodide In acetone for 24h; Heating;75%
4-bromo-phenol
106-41-2

4-bromo-phenol

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-[3-(4-bromo-phenoxy)-propyl]-[1,3]dioxolane

2-[3-(4-bromo-phenoxy)-propyl]-[1,3]dioxolane

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide; potassium carbonate In N,N-dimethyl-formamide at 50℃; for 3h;75%
4-(2-phenyl-1-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)but-1-en-1-yl)phenol

4-(2-phenyl-1-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)but-1-en-1-yl)phenol

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

2-(4-(1-(4-(3-(1,3-dioxolan-2-yl)propoxy)phenyl)-2-phenylbut-1-en-1-yl)phenoxy)tetrahydro-2H-pyran

2-(4-(1-(4-(3-(1,3-dioxolan-2-yl)propoxy)phenyl)-2-phenylbut-1-en-1-yl)phenoxy)tetrahydro-2H-pyran

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 75℃; for 20h;74%
methyl (naphthalen-2-ylmethyl) oxalate

methyl (naphthalen-2-ylmethyl) oxalate

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

C17H20O2

C17H20O2

Conditions
ConditionsYield
With manganese; nickel dibromide; tris(para-trifluoromethyl)phenyl phosphine In dimethyl sulfoxide; N,N-dimethyl-formamide at 30℃; for 24h;73%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

1-bromo-2-(3-methylbut-3-en-1-yl)benzene
130955-17-8

1-bromo-2-(3-methylbut-3-en-1-yl)benzene

C17H24O2

C17H24O2

Conditions
ConditionsYield
With nickel(II) bromide dimethoxyethane; (R,R)-4,4'-bis(phenylmethyl)-2,2',5,5'-tetrahydro-2,2'-bioxazole; zinc In N,N-dimethyl acetamide at 40℃; for 10h; Inert atmosphere; Sealed tube; enantioselective reaction;71%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

3-iodopropionaldehyde ethylene acetal
58135-25-4

3-iodopropionaldehyde ethylene acetal

Conditions
ConditionsYield
With lithium iodide In tetrahydrofuran Finkelstein reaction; Heating;68%
C22H33NO5

C22H33NO5

2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

C26H38O6

C26H38O6

Conditions
ConditionsYield
Stage #1: 2-(3-bromopropyl)-1,3-dioxolane With iodine; magnesium In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
Stage #2: C22H33NO5 In tetrahydrofuran at 20℃; Inert atmosphere;
68%
2-(3-bromopropyl)-1,3-dioxolane
62563-07-9

2-(3-bromopropyl)-1,3-dioxolane

1-bromo-2-(3-methylbut-3-en-1-yl)benzene
130955-17-8

1-bromo-2-(3-methylbut-3-en-1-yl)benzene

C17H24O2

C17H24O2

Conditions
ConditionsYield
With pyridine-2-yl-N-cyanoamidine; nickel dibromide; zinc In N,N-dimethyl acetamide at 55℃; for 10h;67%

62563-07-9Relevant articles and documents

Chemoselective Oxidation of Equatorial Alcohols with N-Ligated λ3-Iodanes

Mikhael, Myriam,Adler, Sophia A.,Wengryniuk, Sarah E.

supporting information, p. 5889 - 5893 (2019/08/26)

The site-selective and chemoselective functionalization of alcohols in complex polyols remains a formidable synthetic challenge. Whereas significant advancements have been made in selective derivatization at the oxygen center, chemoselective oxidation to the corresponding carbonyls is less developed. In cyclic systems, whereas the selective oxidation of axial alcohols is well known, a complementary equatorial selective process has not yet been reported. Herein we report the utility of nitrogen-ligated (bis)cationic λ3-iodanes (N-HVIs) for alcohol oxidation and their unprecedented levels of selectivity for the oxidation of equatorial over axial alcohols. The conditions are mild, and the simple pyridine-ligated reagent (Py-HVI) is readily synthesized from commercial PhI(OAc)2 and can be either isolated or generated in situ. Conformational selectivity is demonstrated in both flexible 1,2-substituted cyclohexanols and rigid polyol scaffolds, providing chemists with a novel tool for chemoselective oxidation.

Synthesis method of 5-fluoro-2-(1-bromocyclopropyl) pyridine

-

Paragraph 0016; 0023; 0027; 0034; 0038; 0045, (2019/08/01)

The invention relates to a synthesis method of 5-fluoro-2-(1-bromocyclopropyl) pyridine. 1,4-butyrolactone, ethyl 4-bromobutyrate and 5-fluoro-2-mercaptopyridine are used as raw materials to prepare 5-fluoro-2-(1-bromocyclopropyl) pyridine through eleven steps of reaction. A synthetic route of the 5-fluoro-2-(1-bromocyclopropyl) pyridine is as follows: (as described in the specification). The invention has the advantages that the synthesis method of 5-fluoro-2-(1-bromocyclopropyl) pyridine improves the yield and provides an efficient synthesis method for the synthesis of the compound.

(Poly)cationic λ3-Iodane-Mediated Oxidative Ring Expansion of Secondary Alcohols

Walters, Jennifer C.,Tierno, Anthony F.,Dubin, Aimee H.,Wengryniuk, Sarah E.

supporting information, p. 1460 - 1464 (2018/04/06)

Herein, a simplified approach to the synthesis of medium-ring ethers through the electrophilic activation of secondary alcohols with (poly)cationic λ3-iodanes (N-HVIs) is reported. Excellent levels of selectivity are achieved for C–O bond migration over established α-elimination pathways, enabled by the unique reactivity of a novel 2-OMe-pyridine-ligated N-HVI. The resulting hexafluoroisopropanol (HFIP) acetals are readily derivatized with a range of nucleophiles, providing a versatile functional handle for subsequent manipulations. The utility of this methodology for late-stage natural product derivatization was also demonstrated, providing a new tool for diversity-oriented synthesis and complexity-to-diversity (CTD) efforts. Preliminary mechanistic investigations reveal a strong effect of alcohol conformation on the reactive pathway, thus providing a predictive power in the application of this approach to complex molecule synthesis.

Mechanistic Studies on the Organocatalytic α-Chlorination of Aldehydes: The Role and Nature of Off-Cycle Intermediates

Ponath, Sebastian,Menger, Martina,Grothues, Lydia,Weber, Manuela,Lentz, Dieter,Strohmann, Carsten,Christmann, Mathias

supporting information, p. 11683 - 11687 (2018/09/10)

Herein we report the isolation and characterization of aminal intermediates in the organocatalytic α-chlorination of aldehydes. These species are stable covalent ternary adducts of the substrate, the catalyst and the chlorinating reagent. NMR-assisted kinetic studies and isotopic labeling experiments with the isolated intermediate did not support its involvement in downstream stereoselective processes as proposed by Blackmond. By tuning the reactivity of the chlorinating reagent, we were able to suppress the accumulation of rate-limiting off-cycle intermediates. As a result, an efficient and highly enantioselective catalytic system with a broad functional group tolerance was developed.

Total synthesis and structural revision of the alkaloid IncargranineB

Brown, Patrick D.,Willis, Anthony C.,Sherburn, Michael S.,Lawrence, Andrew L.

supporting information, p. 13273 - 13275 (2014/01/06)

Seeing double: Consideration of the biosynthetic origins of incargranineB, which was originally assigned an unprecedented indolo[1.7]naphthyridine structure, led to the proposal of a dipyrroloquinoline framework as a more biosynthetically feasible structure (see scheme; Piv=pivaloyl). This hypothesis was validated by a short biomimetic synthesis of incargranineB.

Enantioselective aldehyde α-nitroalkylation via oxidative organocatalysis

Wilson, Jonathan E.,Casarez, Anthony D.,MacMillan, David W. C.

supporting information; body text, p. 11332 - 11334 (2011/03/21)

(Chemical Equation Presented) The first enantioselective organocatalytic α-nitroalkylation of aldehydes has been accomplished. The aforementioned process involves the oxidative coupling of an enamine intermediate, generated transiently via condensation of an amine catalyst with an aldehyde, with a silyl nitronate to produce a β-nitroaldehyde. Two methods, one that furnishes the syn β-nitroaldehyde and a second that provides access to the anti isomer, have been developed. Data are presented to support a hypothesis that explains this phenomenon in terms of a silyl group-controlled change in mechanism. Finally, a three-step procedure for the synthesis of both syn- and anti-α,β-disubstituted β-amino acids is presented.

A synthesis of (±)-stemoamide using the intramolecular propargylic Barbier reaction

Bates, Roderick W.,Sridhar

experimental part, p. 1979 - 1981 (2010/06/17)

A diastereoselective synthesis of the alkaloid stemoamide has been achieved using the intramolecular propargylic Barbier reaction to construct the seven-membered ring. Georg Thieme Verlag Stuttgart.

A novel palladium-catalyzed arylation - dehydroaromatization reaction: Synthesis of 7-aryltetralones

Varseev, Georgy N.,Maier, Martin E.

, p. 3881 - 3884 (2007/10/03)

(Chemical Equation Presented) A new one-pot room-temperature palladium-catalyzed synthesis of 7-aryltetralones was discovered. This tandem process includes a palladium-catalyzed γ-selective arylation of the enone 4 followed by a dehydrogenation-aromatization of the initial cross-coupling product.

Asymmetric synthesis and structural assignment of (-)-α-conhydrine

Enders, Dieter,Nolte, Bert,Raabe, Gerhard,Runsink, Jan

, p. 285 - 291 (2007/10/03)

The first asymmetric synthesis of the conium alkaloid (-)-α-conhydrine is reported. Starting from a protected glycol aldehyde hydrazone as chiral precusor, a short route based on our α-alkylation/1,2-addition methodology has been developed. After cleavage of the auxiliary and simultaneous deprotection, the concluding ring closure is accomplished under reductive amination conditions. The title compound is obtained in moderate overall yield and in excellent diastereo- and enantiomeric excess (d.e., e.e. >96%). Single-crystal X-ray crystallography as well as 1H NMR NOE experiments confirm the expected relative and absolute (2R,7S)-configuration of the product.

SYNTHESES OF PROSTAGLANDIN AND LEUKOTRIENE C7 SYNTHONS THROUGH COMMON INTERMEDIATE COMPOUNDS

Bobrova, N. I.,Belosludtsev, Yu. Yu.,Pivnitskii, K. K.

, p. 1873 - 1878 (2007/10/02)

A method is proposed for the production of the C7-synthons used in the synthesis of eicosanoids (the methyl esters of 7-hydroxy-5Z-heptenoic and 6-formyl-5,6-trans-epoxyhexanoic acids) by a common scheme from readily obtainable tetrahydrofuran and propargyl alcohol.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 62563-07-9